News | August 10, 2023
Granules India posts Q1 FY24 revenue from operations at Rs. 985.5 Cr
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The inspection was conducted at its Goa, Vema manufacturing facility
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Subscribe To Our Newsletter & Stay Updated
